Method for producing muscle fiber-like tissue, and apparatus for producing muscle fiber-like tissue
The method produces oriented three-dimensional bovine muscle-like tissue by aggregating fibroblasts into myogenic aggregates and applying tension with metal anchors, overcoming the resource and environmental issues of scaffold protein reliance and achieving structured muscle tissue.
Patent Information
- Application Number
- JP2023083759
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-22
- Publication Date
- 2024-12-04
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for producing cultured meat using scaffold proteins like collagen require animal-derived materials, leading to resource and environmental issues, and existing techniques fail to produce oriented three-dimensional muscle tissue suitable for edible meat.
A method involving the production of spheroids from fibroblasts, aggregation into myogenic aggregates, adhesion culture with anchor members, and application of tension to these aggregates using a mesh-like metal anchor system to create oriented three-dimensional muscle tissue without scaffold proteins.
This method enables the production of oriented three-dimensional bovine muscle-like tissue without animal-derived scaffold proteins, addressing resource and environmental concerns and achieving a structured muscle tissue similar to natural muscle fibers.
Smart Images

Figure 2024167581000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a method and an apparatus for producing muscle fibrous tissue, which is a raw material for artificial meat, using cells from bovine or other organisms. [Background technology]
[0002] Currently, meat from livestock such as cattle is obtained by slaughtering cattle and other livestock using grains as feed. In the process of producing cattle meat for consumption, it has been pointed out that the methane gas emitted by the cattle's stomach ruminating the feed contributes to global warming, and that the vast amount of land and water required to raise cattle contributes to deforestation and water resource problems. In response to this, the production of cultured bovine meat using cellular agriculture is being considered. One method of producing cultured meat is to culture bovine cells in a medium that uses grains as nutrients, produce cultured tissue, and turn it into cultured meat. Bovine cell culture does not emit methane gas, so global warming is suppressed. Bovine cell culture requires less land and water, so it is thought to prevent deforestation and water resource problems.
[0003] For culturing bovine cells, a technique has been developed in which bovine myoblasts are cultured by adhering the cells to a scaffold protein, such as collagen extracted from bovine hide or tendons.
[0004] As such a technique, for example, Patent Document 1 discloses a cell culture method, a method for producing an artificial tissue, a drug evaluation method, and an artificial tissue body, which include a step of preparing a cell fiber containing cells dispersed in a fibrous matrix of an edible gel, and a step of culturing the cells. This technique aims to provide a cell culture method, a method for producing an artificial tissue, a drug evaluation method, and an artificial tissue body that provide an artificial tissue with improved edibility for consumption.
[0005] Furthermore, as a method for producing cell tissue without using a scaffold material, for example, Patent Document 2 discloses a method for producing a three-dimensional cell aggregate, which includes a cell containing step of containing a cell suspension in a cell containing container and a pressure applying step of applying pressure to the cells in the container, in which the cell containing step and the pressure applying step are repeated two or more times, and in the second and subsequent cell containing steps, further cells are added to the cells contained in the cell containing container. This technology aims to provide a means that makes it possible to produce a thick cell aggregate in a simple process without the need for an operation of peeling and stacking the cells. [Prior art documents] [Patent documents]
[0006] [Patent Document 1] JP 2023-47343 A [Patent Document 2] Patent No. 6733126 Summary of the Invention [Problem to be solved by the invention]
[0007] In the method of culturing livestock cells such as cattle using scaffold proteins, the scaffold proteins such as collagen must be extracted directly from the animals. This is because collagen cannot yet be efficiently synthesized. In other words, meat cultivation that relies on scaffold proteins such as collagen ultimately requires the raising of cattle and the extraction of components. Therefore, it is not possible to fundamentally solve the problems of resources, environment, etc. required in the process of slaughtering livestock such as cattle using feed such as grains.
[0008] In addition, the technology of Patent Document 1 uses alginate gel as the gellable material, but since alginate gel interferes with single cells fusing together to form three-dimensional tissue, it is not necessarily suitable for producing three-dimensional muscle tissue with an orientation that can be used for edible meat.
[0009] The technology of Patent Document 2 also discloses a method in which the pressure application step is performed in the absence of a porous three-dimensional scaffold material. Using this method, cells can be cultured without the need for scaffold proteins such as collagen. However, this technology is not a technology for producing three-dimensional muscle tissue with orientation that can be used for edible meat, and no method is disclosed for imparting orientation to cells. Even if the technology of Patent Document 2 is used for culturing without using scaffold proteins, only cell mass-like tissue without any particular orientation can be produced.
[0010] For this reason, there is a strong demand for a technology that can effectively produce oriented three-dimensional muscle tissue without using a separate scaffold protein such as collagen. The present invention has been made in consideration of the above-mentioned circumstances, and its object is to provide a method and an apparatus for producing muscle fibrous tissue that can produce oriented three-dimensional bovine muscle-like tissue without using so-called scaffold proteins. [Means for solving the problem]
[0011] In order to solve the above problems, the present invention has the following aspects. Aspect 1 of the present invention is a spheroid production process for producing spheroids from fibroblasts; a step of producing a myogenic aggregate by aggregating the spheroids; an adhesion culture step of culturing the myogenic aggregates adjacent to a plurality of anchor members; a tension application step of applying tension to the myogenic aggregate by separating the anchor member fixed to the myogenic aggregate from each other; The present invention relates to a method for producing muscle fibrous tissue, comprising the steps of:
[0012] Aspect 2 of this embodiment is The method for producing muscle fibrous tissue according to embodiment 1 uses bovine myoblasts as the fibroblasts.
[0013] Aspect 3 of this embodiment is In the method for producing muscle fibrous tissue according to aspect 1 or 2, the tension application step is performed multiple times while culturing is performed in the adhesion culture step.
[0014] Aspect 4 of this embodiment is The anchor member is a mesh-like plate-like member made of metal, This is a method for producing muscle fibrous tissue according to aspect 1 or 2, wherein when the anchor members are adjacent to a myogenic aggregate in the adhesion culture step, the anchor members are positioned facing each other so as to sandwich the myogenic aggregate.
[0015] Aspect 5 of this embodiment is A device for producing muscle fibrous tissue comprising a cell culture vessel and a tension applying mechanism, The cell culture vessel includes two or more anchor members including a mesh-like plate-like member made of metal, The anchor members are arranged opposite to each other so as to be installable so as to sandwich a myogenic aggregate formed by aggregation of spheroids produced from fibroblasts, The tension application mechanism is an apparatus for producing muscle fibrous tissue, configured so that the anchor members can be separated from each other. Effect of the Invention
[0016] According to the present invention, there is provided a method and an apparatus for producing muscle fibrous tissue, which are capable of producing oriented three-dimensional bovine muscle-like tissue without using so-called scaffold proteins. [Brief description of the drawings]
[0017] [Figure 1] FIG. 2 is a schematic diagram of the method for producing muscle fibrous tissue of the present embodiment. [Diagram 2] FIG. 2 is a schematic diagram of a muscle fibrous tissue manufacturing apparatus according to the present embodiment. [Diagram 3] FIG. 1 is a photograph of myogenic aggregates from Test Example 1. [Figure 4]FIG. 2 is a schematic diagram showing the adhesion culture step and tension application step of Test Example 1, and photographs of the steps observed with a stereomicroscope. [Diagram 5] FIG. 2 is a photograph of the cultured cells of Reference Example 1. [Figure 6] FIG. 1 is a photograph of the cultured cells of Reference Example 2. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0018] Hereinafter, the method and apparatus for producing muscle fibrous tissue according to the present invention will be described with reference to embodiments, although the present invention is not limited to the following embodiments.
[0019] (Method of producing muscle fibrous tissue) 1 is a schematic diagram of the method for producing muscle fibrous tissue of this embodiment. The method for producing muscle fibrous tissue of this embodiment includes a spheroid production step (I) for producing spheroids from fibroblasts, a myogenic aggregate production step (II) for producing myogenic aggregates by aggregating the spheroids, an adhesion culture step (III) for culturing a plurality of the myogenic aggregates adjacent to each other and adjacent to a plurality of anchor members, and a tension application step (IV) for applying tension to the myogenic aggregates by separating the anchor members adhered to the myogenic aggregates from each other.
[0020] Here, the muscle fibrous tissue 100 of this embodiment is a structure including biological tissue similar to fibers in which muscle cells are arranged in the muscle tissue of an organism. The muscle fibrous tissue preferably has a three-dimensional structure in which cells are oriented in one direction, similar to the muscle fibers of an organism. Here, the organism is mainly an animal, and broadly includes humans, non-human livestock animals, and laboratory animals such as mice. In this embodiment, a cow is used.
[0021] In the spheroid production step (I), spheroids 20 are produced from fibroblasts 10. The fibroblasts are preferably derived from the organism that produces the muscle fibrous tissue of the organism. In this embodiment, bovine myoblasts are used as the fibroblasts. The term "spheroid" broadly refers to a mass of cells that have aggregated together, or a mass of cells. Here, it refers to a mass of cells that have aggregated together and have a diameter in the μm range. Specifically, the diameter is 1 to 1000 μm, and preferably 20 to 200 μm.
[0022] The operation of producing spheroids from fibroblasts may be any means capable of culturing and aggregating fibroblasts. For example, fibroblasts may be cultured in suspension in a liquid medium until aggregation occurs. The suspension culture may be performed with shaking or rotation. Alternatively, suspension culture may be performed at a certain cell concentration (cell number per volume of medium) or higher. In this embodiment, bovine myoblasts are cultured in suspension while rotating in a spinner flask to obtain uniform bovine myoblast spheroids with a diameter of about 80 μm.
[0023] In the myogenic aggregate production step (II), the spheroids 20 are aggregated to produce the myogenic aggregate 20. The myogenic aggregate 30 is a mass of a size of mainly mm units formed by the fusion of a plurality of spheroids 20, and has a structure that serves as a base (muscle primordium) for producing muscle fibrous tissue. As a means for aggregating the spheroids 20 to produce the myogenic aggregate 30, since the spheroids will aggregate when cultured adjacent to each other, any culture means that can achieve this can be appropriately used, but it is preferable to use a means that allows the myogenic aggregate to have a size and cell density suitable for the subsequent steps.
[0024] In this embodiment, an agar plate for producing myogenic aggregates is prepared, and spheroids are fused. First, an agar solution is gelled on the plate. At this time, when about 1% agar solution is poured into a 24-well plate or the like and gelled, an agar gel with a concave center is formed. A growth medium containing the spheroids is added thereto, and the mixture is cultured for an appropriate time. In this embodiment, the mixture is cultured stationarily for about 24 hours. The spheroids gather in the concave portion of the center of the agar gel, and aggregate with each other to form myogenic aggregates of several mm. In the example shown in the figure, myogenic aggregates 30 having a shape close to a disk shape with a diameter of 2 to 4 mm and a thickness of about 0.5 to 1 mm are produced according to the shape of the concave portion of the agar gel in the 24-well plate.
[0025] In the adhesion culture step (III), the myogenic aggregate 30 is cultured adjacent to a plurality of anchor members 41, 42.
[0026] In the adhesion culture step, it is preferable to culture the multiple myogenic aggregates adjacent to each other and adjacent to multiple anchor members. The number of multiple myogenic aggregates can be appropriately selected as long as it is 2 or more depending on the scale of the muscle fibrous tissue to be produced, and 2 to 10 is preferable.
[0027] The anchor member is preferably made of a metal. The anchor member is preferably a mesh-like plate-like member. As described below, the anchor member is made of a metal and is a mesh-like plate-like member, so that when the myogenic aggregate is cultured adjacent to the anchor member, the myogenic aggregate is easily fixed to the anchor member.
[0028] In addition, when the anchor member is adjacent to the myogenic aggregate, it is preferable to arrange the anchor members opposite each other so as to sandwich the myogenic aggregate. As described below, by arranging a plurality of anchor members opposite each other and separating the anchor members from each other, tension can be applied to the myogenic aggregate fixed to the anchor members.
[0029] In the example shown in the figure, two myofibril aggregates 30 are stacked with the disk-shaped planar portions adjacent to each other. A number of mesh-like anchor members 41 and 42 made of metal are arranged facing each other on the top and bottom surfaces of two overlapping myogenic aggregates 30. In the figure, they are the top and bottom, but as described below, the orientation of the myogenic aggregate and the anchor members facing both sides of it is not particularly limited with respect to the direction of gravity. The anchor members 41 and 42 are provided in the muscle fibrous tissue producing mechanism 40. Specifically, the planar portions of the support member 44 and the anchor members 41 and 42 are provided approximately parallel to each other via a support post 43, which is mainly made of metal and stands approximately vertically on a plate-like support member 44. The anchor members 41 and 42 are provided so as to be movable along the long side direction of the support post 43.
[0030] In the adhesion culture step, the myogenic aggregates and the anchor member are cultured in a state in which cells can grow. Specifically, it is preferable to culture the myogenic aggregates and the anchor member while immersed in a liquid medium. In the example shown in the figure, the muscle fibrous tissue-producing mechanism 40 is housed in a culture vessel (not shown) filled with liquid medium and immersed in the liquid medium. The culture vessel may have any shape and size as long as it can accommodate the muscle fibrous tissue-producing mechanism 40. In the example shown in the figure, the muscle fibrous tissue-producing mechanism 40 is placed in a 6-well plate and cultured with shaking, tilted horizontally as shown in the figure.
[0031] In the adhesion culture step, the myogenic aggregate is cultured at least until it is fixed to the anchor member. Specifically, by culturing the myogenic aggregate and the anchor member in a state adjacent to each other, the cells contained in the myogenic aggregate grow on the surface of the anchor member in a state of mutual fusion, and the myogenic aggregate and the anchor member are fixed to each other. Alternatively, the cells grow by culture so as to become entangled with the anchor member and to wrap around the surface of the anchor member. This phenomenon is observed when the anchor member is a certain size smaller than the size of the fibroblasts or spheroids, so it is preferable that the anchor member has a thin portion, and it is particularly preferable that the anchor member is a fine mesh. When multiple myogenic aggregates are provided, the myogenic aggregates are cultured until they adhere to each other. Multiple myogenic aggregates adhere to each other when cultured adjacent to each other. The time required for adhesion may be selected appropriately, but as a guideline, the adhesion culture process is continued for 12 to 72 hours, preferably approximately 48 hours, until the myogenic aggregates adhere to the anchor member, or the myogenic aggregates adhere to each other.
[0032] In the tension application step (IV), the anchor members 41, 42 fixed to the myogenic aggregate 30 are moved away from each other, and tension is applied to the myogenic aggregate 30. In the example shown in the figure, anchor member 42 is moved along support 43 relative to anchor member 41 to move anchor members 41, 42 away from each other. Since myogenic aggregate 30 is fixed to anchor members 41, 42, when anchor members 41, 42 are moved away from each other, tension is applied to myogenic aggregate 30 along the direction T of separation.
[0033] The tension application step may be carried out in parallel while the adhesion culture step is continued, or may be carried out continuously or intermittently. The tension application step is preferably performed multiple times while culturing in the adhesion culture step. When the tension application step is performed, the cells are initially pulled in the direction in which the tension is applied, but then the cells that have grown by culture grow with orientation in the direction in which the tension is applied. When the cells have grown sufficiently and the tension is relaxed, the tension application step is performed again. By repeating this operation, a muscle fibrous tissue consisting of cells oriented in one direction can be efficiently produced.
[0034] Here, if the spheroids 10 and myogenic aggregates 20 are continued to be cultured and allowed to aggregate without applying tension, the myogenic aggregates 20 will proliferate and grow in terms of cell number, but as the culture continues, they will continue to shrink and become simple spherical aggregates with no orientation, and it is not possible to obtain muscle fibrous tissue 100.
[0035] The tension application step is preferably performed after the step in which the myogenic aggregate and the anchor member are sufficiently adhered to each other, or, in the case of using multiple myogenic aggregates, after the myogenic aggregates are adhered to each other. In the example shown in the figure, this is after the step (III-1) of the first 48 hours of shaking culture.
[0036] In the example shown in the figure, tension application steps (IV-1) and (IV-2) are performed in parallel with the adhesion culture step (III). After the step (III-1) of the first 48 hours of shaking culture in the adhesion culture step (III), the first tension application step (IV-1) is performed. The tension application step (IV-1) is performed by separating the anchor members 41, 42 by 2 mm and maintaining them as they are. After 72 hours of shaking culture in this state, the second tension application step (IV-2) is performed. In the second tension application step (IV-2), the anchor members 41, 42 are separated by 2 mm, as in the first step.
[0037] After the tension application step, the myogenic aggregates are cultured appropriately to become myofibrillar tissue 100. This culture is performed for approximately 12 to 72 hours, preferably for approximately 48 hours. In myofibrillar tissue 100, cells are oriented along the direction T in which tension is applied, forming a tissue similar to muscle fibers in living organisms.
[0038] After obtaining the muscle fibrous tissue 100, further culture may be performed in a differentiation-inducing medium or the like to form a tissue suitable for the muscle fibrous tissue (not shown). As the differentiation-inducing medium, a DMEM medium containing serum or the like can be used. Culture in the differentiation-inducing medium or the like may be performed for 1 day to 2 weeks, preferably for about 1 week.
[0039] In this embodiment, by culturing the myogenic aggregates produced from spheroids while applying tension, it is possible to produce tissue similar to muscle fibers, in which cells are oriented in one direction. In addition, since the adhesion between the anchor member and the myogenic aggregates can be utilized to apply tension to orient the cells, no scaffold protein is required, and no other materials are required besides the biological cells to be cultured as biological tissue. In addition, the structure required for culturing is simple, making it extremely easy to scale up.
[0040] (Muscle fibrous tissue manufacturing device) The muscle fibrous tissue manufacturing apparatus of this embodiment is an apparatus for manufacturing muscle fibrous tissue comprising a cell culture vessel and a tension application mechanism, wherein the cell culture vessel includes two or more anchor members including a mesh-like plate member made of metal, and the anchor members are arranged opposite each other so as to be installable so as to sandwich a myogenic aggregate formed by the aggregation of spheroids produced from fibroblasts, and the tension application mechanism is configured to be able to separate the anchor members from each other.
[0041] As shown in FIG. 2, the muscle fibrous tissue producing apparatus 200 of this embodiment comprises a cell culture vessel 50 and the muscle fibrous tissue producing mechanism 40 described above. The cell culture vessel 50 is configured to be capable of housing the muscle fibrous tissue-producing mechanism 40, i.e., comprises anchor members 41, 42, struts 43, and support members 44 that are provided in the muscle fibrous tissue-producing mechanism 40. The cell culture vessel 50 is configured to be capable of housing a culture medium 60 capable of culturing fibroblasts. In the example shown in the figure, the culture medium 60 is a liquid culture medium, and is provided so that the muscle fibrous tissue-producing mechanism 40 is immersed in it. In the example shown in Figure 2, the muscle fibrous tissue production mechanism 40 is stored in the cell culture vessel 50 in a horizontal position compared to the example shown in Figure 1, but the muscle fibrous tissue production mechanism 40 may be positioned in any direction relative to the direction of gravity. In the example shown in the figure, anchor members 41 and 42 are placed so as to sandwich myogenic aggregate 30 formed by the aggregation of spheroids 20 produced from fibroblasts 10 .
[0042] The tension applying mechanism is configured to be able to separate the anchor members from each other, and can be appropriately selected as long as it has such a configuration. In this embodiment, the tension applying mechanism refers to the support 43 that can separate the anchor members 41, 42 from each other. In addition, the tension application mechanism may include, for example, a stopper mechanism (not shown) capable of maintaining the anchor members 41, 42 spaced apart, a motor as a mechanism capable of moving the anchor members 41, 42 along the support, and / or a control device thereof (not shown).
[0043] In the example shown in the figure, cell culture vessel 50 is part of a vessel provided in dish 500. Dish 500 is a 6-well plate typically used for cell culture, and cell culture vessel 50 is one of the wells of dish 500. By using dish 500, muscle fibrous tissue-producing mechanism 40 can be provided in each of the multiple wells of cell culture vessel 50, allowing the muscle fibrous tissue producing method to be efficiently carried out.
[0044] The muscle fibrous tissue manufacturing apparatus 200 of the present embodiment can be suitably used in the muscle fibrous tissue manufacturing method described above.
[0045] (Effects of this embodiment) According to the method and apparatus for producing muscle fibrous tissue of the present embodiment, it is possible to produce oriented three-dimensional bovine muscle-like tissue without using so-called scaffold proteins. Furthermore, the tissue can be produced without the need for scaffolds made of other synthetic materials such as alginate gel.
[0046] In this embodiment, it is possible to prepare oriented three-dimensional bovine muscle-like tissue by utilizing the fusion ability of aggregates (spheroids) of bovine myoblasts without using extracellular matrix proteins derived from animals as a scaffold for culture such as collagen and fibrin. In the first step, "preparation of bovine muscle primordia (myogenic aggregates) using bovine myoblasts" was performed, and then, in the second step, "preparation of three-dimensional bovine muscle-like tissue using bovine muscle primordia" was performed. The feature of this preparation method is that, particularly in the second step, not only the fusion between bovine muscle primordia but also the phenomenon that bovine muscle primordia completely adhere (stick) to the stainless steel mesh of the self-made device was discovered and utilized. This allows the preparation of oriented three-dimensional bovine muscle tissue with tension in one direction by fixing both ends with anchors without using extracellular matrix proteins derived from animals as a scaffold for culture.
[0047] As mentioned above, conventionally, when producing cultured bovine meat, myoblasts are suspended in a solution of extracellular matrix proteins (collagen or fibrin), gelled, and bovine myoblasts are three-dimensionally cultured using the gel as a scaffold. Here, both ends of the gel are fixed with anchors and tension is applied in a certain direction to produce oriented bovine muscle fiber tissue (Furuhashi, et al., npj Science of Food, 5:6 (2021) and Kang. et al., Nat. commun., 12:5059 (2021), etc.). However, there are problems with using animal-derived extracellular matrix proteins to produce substitutes for animal meat. In addition, recombinant extracellular matrix proteins are extremely expensive. There have been no reports of the production of "three-dimensional muscle tissue consisting of oriented bovine muscle fibers" without using extracellular matrix proteins.
[0048] In order to produce artificial meat without using extracellular matrix proteins such as collagen and fibrin, the inventors attempted to culture muscle tissue without using anchor proteins. For example, a conventional method for producing three-dimensional tissues without using extracellular matrix proteins is to use pre-prepared cell sheets or cell aggregates (spheroids) as building blocks and further fuse the building blocks together (cell sheet Tanaka et al., npj Science of Food 6:41 (2022), cell aggregate TissueByNet).
[0049] However, the fusion of cell sheets or spheroids alone is not enough to create "three-dimensional muscle tissue consisting of oriented muscle fibers," which can be achieved by fixing both ends with anchors and applying tension in a certain direction. Without anchors, the muscle tissue cannot maintain its string-like shape, and it shrinks into a round shape due to the tension of the cells themselves, making it impossible to obtain oriented muscle fiber-like tissue.
[0050] Therefore, the researchers attempted to use bovine myoblast cell aggregates as the starting material, further fusing the cell aggregates together to produce extracellular matrix proteins (such as collagen), while three-dimensionally culturing the bovine myoblasts while applying tension in one direction, and finally differentiating them to produce cultured meat.
[0051] In this embodiment, the inventors have developed a method for producing oriented three-dimensional bovine muscle-like tissue by utilizing the fusion ability of aggregates (spheroids) of bovine myoblasts without using animal-derived extracellular matrix proteins as a culture scaffold such as collagen or fibrin. A feature of this method is that it has been discovered and utilized the phenomenon that bovine muscle primordia not only fuse with each other, but also completely adhere (stick) to the stainless steel mesh of a homemade device. This makes it possible to produce oriented three-dimensional bovine muscle-like tissue with tension in one direction by fixing both ends with anchors without using animal-derived extracellular matrix proteins as a culture scaffold. This research tackles the current problems of food (protein supply) and environmental problems (water and land depletion, greenhouse gas emissions) by producing bovine meat without relying on cattle, and can contribute to sustainable development (SDGs), which is extremely significant. EXAMPLES
[0052] Examples will be given below, but the present invention is not limited to the Examples.
[0053] (Test Example 1) The fibroblast cells used were bovine myoblasts (which also contain fibroblasts and adipose precursor cells) obtained by culturing satellite cells taken from cattle meat.
[0054] (Step 1: Preparation of myogenic aggregates using bovine myoblasts) Spheroid production process: First, bovine myoblast single cells were aggregated to produce bovine myoblast spheroids. Specifically, 300 × 10 bovine myoblast cells were added to a spinner flask containing 20 mL of growth medium (DMEM medium containing 10% fetal bovine serum (FBS) and 5 ng / mL bFGF). 4 The cells were seeded and cultured in suspension at 40 rpm for 24 hours. During this process, the bovine myoblasts aggregated to form spheroids. The resulting spheroid culture solution was collected in a 15 mL tube, centrifuged (1000 rpm, 5 min) to remove the supernatant, and 1 mL of fresh growth medium was added and suspended to obtain a spheroid suspension.
[0055] Myogenic aggregate production process: Next, the bovine myoblast spheroids produced above were further aggregated to produce bovine muscle primordia. Specifically, the above spheroid suspension was seeded on a 24-well agar plate (a 24-well plate coated with 500 μL of 1% agar solution) and cultured for 24 hours. An agar gel with a depression in the center was formed inside the well, and spheroids gathered in this depression and further aggregated to produce myogenic aggregates (bovine muscle primordia).
[0056] Figure 3 shows photographs of the myogenic aggregates that were created. (a) shows the process of creating spheroids and muscle primordia (myogenic aggregates) from single cells in this example. (b) shows the process of adding single cells directly to the agar gel to create myogenic aggregates. As shown in (a), the photograph shows that the diameter of a single cell is about 10 μm, the spheroid is about 80 μm, and the muscle primordium (myogenic aggregate) is about 3 mm. In this example, a disk-shaped myogenic aggregate with a diameter of about 3 mm was produced, and this myogenic aggregate was sturdy and easy to handle with tweezers. It was thought that tension could be applied in the process described below. In contrast, when attempting to produce myogenic aggregates by directly using single cells instead of spheroids as in (b), the resulting cell masses were weakly bonded and fragile, making them impossible to handle with tweezers, and it seemed unlikely that they could be used in the tension application process described below. These results demonstrated that the myogenic aggregates required for the process described below can be produced by going through a spheroid production process in which spheroids are first formed from single cells, and then a myogenic aggregate production process in which the spheroids are aggregated into myogenic aggregates.
[0057] (Step 2: Creation of 3D bovine muscle tissue using myogenic aggregates) Adhesion culture process: Two of the myogenic aggregates (bovine muscle primordia) prepared above were placed inside the homemade device (the muscle fibrous tissue manufacturing system 40 described above), and the bovine muscle primordia were sandwiched between two stainless steel meshes (anchor members). Here, the homemade device was made of stainless steel mesh (10 mm × 10 mm (= 1 cm 2 ), wire diameter 140 μm, mesh size 283 μm, aperture ratio 44.4%), and three stainless steel rods (supports 43) (diameter 300 μm, length 30 mm). The homemade device was then placed on its side and cultured with shaking in a 6-well plate containing growth medium.
[0058] Tension application process: 48 hours after the start of shaking culture, the gap between the stainless steel meshes was widened by about 2 mm for the first time. Shaking culture was then continued for another 72 hours, and 120 hours after the start of culture, the gap between the stainless steel meshes was widened by about 2 mm for the second time. After culturing in the proliferation medium for 48 hours, the cells were cultured in the differentiation induction medium (DMEM medium containing 2% horse serum) for an additional 7 days.
[0059] FIG. 4 shows a schematic diagram illustrating the adhesion culture process (tension application process) and photographs of the process observed with a stereomicroscope. As shown in the photograph, at 0 hours, two myogenic aggregates were sandwiched between meshes and subjected to adhesion culture, and at 48 hours, the two myogenic aggregates had fused, and the upper and lower ends of the myogenic aggregates were fixed to the mesh. At 48 hours, the gap between the stainless steel meshes was widened by 2 mm for the first time, and at 120 hours, the gap between the stainless steel meshes was widened by 2 mm for the second time, and culture was continued for up to 168 hours. At 168 hours, as shown in the schematic diagram, the cells were oriented along the direction T in which the gap between the meshes was widened (the anchor members were spaced apart from each other), and a cylindrical, cell tissue-like structure with a height of 4 mm and a diameter of 1.5 mm was obtained. In other words, it was demonstrated that muscle fiber-like tissue could be obtained in this process.
[0060] (Reference example 1) As a preparatory step for this example, bovine muscle primordia prepared from cell aggregates of bovine myoblasts were stacked and cultured without applying tension. The cells and culture conditions used were the same as those in Test Example 1.
[0061] Figure 5 shows photographs of this culture. (a) is 10 hours after the start of culture, and (b) is 48 hours after. These bovine muscle primordia fuse together, but they shrink rapidly as culture continues, and after 48 hours they have become simple, unoriented, spherical aggregates. Even when cultured without applying tension, it was not possible to obtain oriented muscle fiber-like tissue.
[0062] (Reference example 2) As a preparatory step for this example, cell aggregates of bovine myoblasts were seeded on a stainless steel mesh and statically cultured in a growth medium. The cells, stainless steel mesh, and other culture conditions used were the same as those in Test Example 1.
[0063] Figure 6 shows photographs of this culture. (a) is one day after the start of culture, (b) is two days, and (c) is four days. As shown in the figure, cell aggregates adhered to the mesh as the culture progressed, and the cells completely wrapped around and covered every corner of the mesh holes as the culture progressed. In other words, by culturing myogenic aggregates adjacent to a mesh-shaped anchor member, the myogenic aggregates adhere relatively firmly to the anchor member, indicating the possibility of applying this method to processes in which tension can be applied to the myogenic aggregates.
[0064] From the results of Reference Examples 1 and 2, the inventors discovered that not only do bovine muscle primordia fuse with each other, but that bovine muscle primordia also completely adhere (stick) to stainless steel mesh. By utilizing this phenomenon, they came up with the idea that it is possible to create three-dimensional bovine muscle tissue with orientation under tension in one direction by fixing both ends with anchors, without using animal-derived extracellular matrix proteins as a culture scaffold. [Industrial Applicability]
[0065] According to the present invention, there is provided a method and an apparatus for producing muscle fibrous tissue, which are capable of producing oriented three-dimensional bovine muscle-like tissue without using so-called scaffold proteins. [Explanation of symbols]
[0066] 10 Fibroblasts 20 Spheroids 30 Myogenic aggregates 40 Muscle fibrous tissue manufacturing mechanism 41, 42 Anchor member 43 Post 44 Support member 50 cell culture vessels 60 Culture medium 100 Muscle fibrous tissue 200 Manufacturing equipment 500 dishes T direction
Claims
1. a spheroid production process for producing spheroids from fibroblasts; a step of producing a myogenic aggregate by aggregating the spheroids; an adhesion culture step of culturing the myogenic aggregates adjacent to a plurality of anchor members; a tension application step of applying tension to the myogenic aggregate by separating the anchor member fixed to the myogenic aggregate from each other; A method for producing muscle fibrous tissue, comprising:
2. The method for producing muscle fibrous tissue according to claim 1 , wherein the fibroblasts are bovine myoblasts.
3. The method for producing muscle fibrous tissue according to claim 1 or 2, wherein the tension application step is performed multiple times while culturing is performed in the adhesion culture step.
4. The anchor member is a mesh-like plate-like member made of metal, The method for producing muscle fibrous tissue according to claim 1 or 2, wherein the anchor members are positioned opposite each other so as to sandwich the myogenic aggregate when adjacent to the myogenic aggregate during the adhesion culture step.
5. A device for producing muscle fibrous tissue comprising a cell culture vessel and a tension applying mechanism, The cell culture vessel includes two or more anchor members including a mesh-like plate-like member made of metal, The anchor members are arranged opposite to each other so as to be installable so as to sandwich a myogenic aggregate formed by aggregation of spheroids produced from fibroblasts, The tension application mechanism is configured to be able to move the anchor members apart from each other, in this apparatus for manufacturing muscle fibrous tissue.
Citation Information
Patent Citations
Cell culture method, artificial tissue production method, drug evaluation method, and artificial tissue body
JP2023047343A
Method for producing three-dimensional cell aggregates
JP6733126B2
